V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220008719 | 220016421 | null | 44.9 | Palliative (P) | 2018-02-26 | 2018-03-22 | CARBOPLATIN | N | N | 220035104 | CARBOPLATIN |
| 220008720 | 220019008 | null | 66 | Palliative (P) | 2015-07-05 | 2015-07-21 | ECX | N | N | 220035105 | ECX |
| 220008723 | 220003522 | 1.6 | 29.8 | Palliative (P) | 2014-01-21 | 2014-01-21 | Carboplatin + Etoposide iv&po | 02 | N | 220035110 | CARBOPLATIN + ETOPOSIDE |
| 220008724 | 220003523 | 1.7 | 90 | null | 2015-11-08 | 2016-12-18 | CARBOPLATIN | N | N | 220035112 | CARBOPLATIN |
| 220008725 | 220003523 | 0 | null | Palliative (P) | 2010-11-08 | 2014-12-02 | FLAG | N | N | 220035112 | FLAG |
| 220008726 | 220003523 | 1.78 | 70.4 | Palliative (P) | 2013-07-25 | 2013-08-03 | Rituximab (Maintenance) | N | N | 220035112 | PEMBROLIZUMAB |
| 220008727 | 220003524 | 0 | 77.9 | Palliative (P) | 2015-07-17 | 2015-07-20 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 220035115 | RITUXIMAB |
| 220008733 | 220003526 | 1.68 | 66.6 | Curative (C) | 2013-12-03 | 2013-12-04 | Cytarabine High Dose | N | N | 220035126 | CYTARABINE HIGH DOSE |
| 220008740 | 220019010 | 1.51 | 81.4 | Not known (9) | 2014-01-29 | 2014-02-04 | RAVVA TRIAL | N | N | 220035137 | GEMCITABINE |
| 220008741 | 220003529 | 1.85 | null | Palliative (P) | 2014-03-24 | 2014-03-26 | Rituximab | N | N | 220035140 | PEMBROLIZUMAB |
| 220008742 | 220003530 | 1.8 | 103 | Curative (C) | null | 2013-03-24 | FLAG | N | N | 220035142 | FLAG |
| 220008743 | 220003531 | 1.63 | 63.5 | Not known (9) | 2014-05-20 | 2014-05-20 | Rituximab | 02 | N | 220035144 | RITUXIMAB |
| 220008744 | 220003532 | null | 65 | Palliative (P) | 2015-11-12 | 2015-11-12 | ECX | N | null | 220035146 | ECX |
| 220008745 | 220003533 | null | 58 | Palliative (P) | 2018-06-08 | 2018-06-19 | Carboplatin + Etoposide IV 3 day | N | N | 220035151 | CARBOPLATIN + ETOPOSIDE |
| 220008746 | 220003534 | 1.73 | 97.4 | Curative (C) | null | 2016-07-19 | AML Int Guide ADE 10+3+5 (1) | N | N | 220035152 | ADE |
| 220008747 | 220003535 | 1.78 | null | Not known (9) | 2013-07-22 | 2013-07-30 | ECX | 02 | N | 220035156 | ECX |
| 220008748 | 220003535 | 1.61 | null | Curative (C) | 2015-10-18 | 2015-10-25 | FLAG | Y | N | 220035156 | FLAG |
| 220008749 | 220003535 | 1.87 | 76.6 | Curative (C) | 2015-02-22 | 2015-02-22 | RAVVA TRIAL | N | N | 220035156 | RAVVA TRIAL |
| 220008750 | 220003535 | 1.65 | 102 | Curative (C) | null | 2015-02-20 | Cisplatin + Radiotherapy | 02 | N | 220035156 | CISPLATIN + RT |
| 220008751 | 220003535 | 1.78 | null | Curative (C) | 2016-07-21 | 2016-08-01 | CISPLATIN + RT | N | N | 220035156 | CISPLATIN + RT |
| 220008754 | 220016427 | 1.55 | 57.5 | Curative (C) | 2017-06-04 | 2017-06-05 | FLAG | 02 | null | 220035169 | FLAG |
| 220008755 | 220003537 | 1.84 | 56.6 | null | 2013-05-07 | 2013-05-21 | Cisplatin 100 + RT(H&N) 1 day | N | N | 220035170 | CISPLATIN + RT |
| 220008756 | 220011931 | 1.68 | 94 | Curative (C) | 2015-11-16 | 2015-11-16 | Gemcitabine weekly | Y | N | 220035171 | PEMBROLIZUMAB |
| 220008757 | 220011931 | null | 92.4 | Palliative (P) | 2013-12-10 | 2013-12-20 | EOX | N | N | 220035171 | EOX |
| 220008758 | 220011931 | 1.78 | 63.3 | Not known (9) | 2014-04-09 | 2014-04-28 | Gemcitabine 1000mg/m2 D1 8 15 | Y | N | 220035171 | RITUXIMAB |
| 220008759 | 220011931 | 1.66 | 55 | Curative (C) | 2014-02-20 | 2014-02-20 | Carboplatin AUC 2 - 5 | 02 | N | 220035171 | CARBOPLATIN |
| 220008760 | 220011931 | 1.59 | 52.7 | Curative (C) | 2015-10-05 | 2015-10-06 | CISPLATIN + RT | N | null | 220035171 | CISPLATIN + RT |
| 220008761 | 220003538 | 1.83 | 84.4 | null | 2013-05-07 | 2013-05-27 | ATG + Busulfan + Fludarabine | N | N | 220035181 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 220008762 | 220003538 | 1.58 | 62.3 | Palliative (P) | 2014-03-25 | 2014-03-25 | IPILIMUMAB + NIVOLUMAB | 02 | N | 220035181 | CAPECITABINE + GEMCITABINE |
| 220008766 | 220003540 | 1.73 | 56.2 | Palliative (P) | 2015-12-17 | 2015-12-17 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 220035188 | BUSULPHAN |
| 220008767 | 220003541 | 1.93 | 0 | Palliative (P) | 2016-08-01 | 2016-08-01 | Dacarbazine | 2 | N | 220035189 | GEMTUZUMAB OZOGAMICIN |
| 220008768 | 220003542 | 0 | null | null | 2017-01-15 | 2017-01-15 | BUSULFAN + CYCLOPHOSPHAMIDE | N | N | 220035190 | CHOP R |
| 220008769 | 220003543 | 1.77 | 93.6 | Palliative (P) | 2016-12-11 | 2016-12-25 | ALL UKALL2011 TRIAL | N | N | 220035194 | CAPECITABINE + STREPTOZOCIN |
| 220008770 | 220003544 | null | 55.2 | null | null | 2017-02-10 | ECF | null | null | 220035195 | UKALL 2011 |
| 220008771 | 220003545 | 1.62 | 0 | Palliative (P) | 2014-03-27 | 2014-03-27 | Arsenic trioxide + Tretinoin | 02 | N | 220035196 | DABRAFENIB |
| 220008772 | 220003546 | 1.7 | 99 | Palliative (P) | 2016-10-05 | 2016-10-05 | Dacarbazine | N | N | 220035197 | DOCETAXEL |
| 220008773 | 220003546 | 1.56 | null | Palliative (P) | null | 2017-01-18 | Triple / Double Intrathecal Therapy | null | null | 220035197 | MITOXANTRONE |
| 220008774 | 220003546 | 1.58 | null | Palliative (P) | 2016-06-05 | 2016-06-10 | CISPLATIN + FLUOROURACIL | 02 | null | 220035197 | PACLITAXEL |
| 220008775 | 220003547 | 1.7 | 73.6 | Palliative (P) | 2015-01-26 | 2015-01-27 | Ipilimumab | 2 | N | 220035200 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 220008776 | 220003548 | 1.7 | 82 | Palliative (P) | 2015-05-05 | 2015-05-06 | Carboplatin + Vinorelbine Oral | N | N | 220035201 | DABRAFENIB |
| 220008777 | 220003548 | 0 | 82 | Palliative (P) | 2014-12-06 | 2014-12-07 | Abiraterone | N | N | 220035201 | CISPLATIN + ETOPOSIDE |
| 220008778 | 220003549 | 1.64 | 68.6 | Neo-adjuvant (N) | 2014-01-13 | 2014-01-28 | CYTARABINE + ETOPOSIDE + IDARUBICIN | N | N | 220035208 | CAP + RT |
| 220008779 | 220003549 | 0.01 | 69 | Palliative (P) | 2014-09-17 | 2014-09-18 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220035208 | DABRAFENIB + TRAMETINIB |
| 220008780 | 220003549 | 1.62 | null | null | 2014-06-24 | 2014-07-08 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 220035208 | SPIRIT TRIAL |
| 220008781 | 220003549 | 1.55 | 58.9 | Neo-adjuvant (N) | 2014-01-29 | 2014-01-29 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220035208 | CISPLATIN + PEMETREXED |
| 220008782 | 220003550 | 1.77 | 56 | Palliative (P) | 2014-08-03 | 2014-08-06 | Cisplatin + Pemetrexed | 02 | N | 220035221 | IPILIMUMAB + NIVOLUMAB |
| 220008783 | 220003551 | 1.78 | 90 | Palliative (P) | 2015-06-20 | 2015-06-28 | DABRAFENIB | N | N | 220035222 | CAPECITABINE + CISPLATIN |
| 220008784 | 220003552 | 1.64 | 93 | Palliative (P) | 2013-11-09 | 2013-11-23 | Mitoxantrone | N | N | 220035223 | MITOXANTRONE |
| 220008785 | 220003553 | 1.54 | 88.5 | Palliative (P) | 2016-03-16 | 2016-03-17 | CETUXIMAB | Y | N | 220035224 | CISPLATIN + PEMETREXED |
| 220008786 | 220003553 | 1.85 | 79.5 | Palliative (P) | 2017-09-08 | 2017-09-09 | BOSUTINIB | 2 | N | 220035224 | CISPLATIN + DOCETAXEL + FLUOROURACIL |